...
首页> 外文期刊>European spine journal >Augmented reality and artificial intelligence-based navigation during percutaneous vertebroplasty: a pilot randomised clinical trial
【24h】

Augmented reality and artificial intelligence-based navigation during percutaneous vertebroplasty: a pilot randomised clinical trial

机译:经皮椎体成形术期间的增强现实和基于人工智能的导航:试点随机临床试验

获取原文
           

摘要

To assess technical feasibility, accuracy, safety and patient radiation exposure of a novel navigational tool integrating augmented reality (AR) and artificial intelligence (AI), during percutaneous vertebroplasty of patients with vertebral compression fractures (VCFs). This prospective parallel randomised open trial compared the trans-pedicular access phase of percutaneous vertebroplasty across two groups of 10 patients, electronically randomised, with symptomatic single-level VCFs. Trocar insertion was performed using AR/AI-guidance with motion compensation in Group A, and standard fluoroscopy in Group B. The primary endpoint was technical feasibility in Group A. Secondary outcomes included the comparison of Groups A and B in terms of accuracy of trocar placement (distance between planned/actual trajectory on sagittal/coronal fluoroscopic images); complications; time for trocar deployment; and radiation dose/fluoroscopy time. Technical feasibility in Group A was 100%. Accuracy in Group A was 1.68 0.25 mm (skin entry point), and 1.02 0.26 mm (trocar tip) in the sagittal plane, and 1.88 0.28 mm (skin entry point) and 0.86 0.17 mm (trocar tip) in the coronal plane, without any significant difference compared to Group B (p 0.05). No complications were observed in the entire population. Time for trocar deployment was significantly longer in Group A (642 210 s) than in Group B (336 60 s; p = 0.001). Dose area product and fluoroscopy time were significantly lower in Group A (182.6 106.7 mGy cm2 and 5.2 2.6 s) than in Group B (367.8 184.7 mGy cm2 and 10.4 4.1 s; p = 0.025 and 0.005), respectively. AR/AI-guided percutaneous vertebroplasty appears feasible, accurate and safe, and facilitates lower patient radiation exposure compared to standard fluoroscopic guidance. These slides can be retrieved under Electronic Supplementary Material.
机译:在椎体压缩骨折患者(VCFS)患者的经皮椎体成形术后,评估一种新的导航工具的技术可行性,准确性,安全性和患者辐射暴露,这是一种新的导航工具和人工智能(AI)的经皮椎体术(VCF)。该前瞻性平行随机开放试验比较了两组10名患者的经皮椎体成形术的跨界进入阶段,以电子方式随机化,具有症状单级VCF。使用Ar / Ai-Grawance在A组A的运动补偿和B组中的标准荧光透视方法进行套管针。初级终点是A组技术可行性。二次结果包括在套球针的准确性方面的组A和B的比较放置(矢状/冠状荧光透视图像上计划/实际轨迹之间的距离);并发症;套管针部署的时间;和辐射剂量/透视时间。 A组技术可行性为100%。 A组的准确性为1.68 0.25 mm(皮肤入口点),矢车场中的1.02 0.26 mm(套管针),1.88 0.28 mm(皮肤入口点)和0.86 0.17 mm(套管针尖端),没有与B组相比的任何显着差异(P> 0.05)。在整个人口中没有观察到任何并发症。在A(642 210s)组中,套管针部署的时间比B组(33660秒; P = 0.001)在显着更长。剂量区域产品和透视时间分别比B组(367.8184.7 MGY CM2和10.4 4.1s; P = 0.025和0.005)显着降低(182.6 106.7 mg2和5.2 2.6 s)。与标准荧光透视引导相比,AR / AI引导的经皮椎体成型术似乎可行,准确和安全,促进患者辐射暴露。这些幻灯片可以在电子补充材料下检索。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号